In vivo kinetic analysis of covalent binding between N-acetyl-L-cysteine and plasma protein through the formation of mixed disulfide in rats

被引:26
作者
Harada, D
Naito, S
Hiraoka, I
Otagiri, M
机构
[1] Otsuka Pharmaceut Factory INc, Naruto Res Inst, Tokushima 7728601, Japan
[2] Kumamoto Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Kumamoto 862, Japan
关键词
N-acetyl-L-cysteine; plasma protein; covalent binding; mixed-disulfide; kinetic analysis; compartmental method;
D O I
10.1023/A:1015349928000
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. This investigation was undertaken to study the relationship between plasma drug clearance and covalent protein-binding kinetics of N-acetyl-L-cysteine (NAC). Methods. NAC was intravenously administered to rats via a bolus injection or continuous infusion. Plasma concentrations of protein-unbound and total NAC were analyzed using a compartment model, taking into consideration of the protein binding process, and the apparent first-order binding and dissociation rate constants (k(o)n and k(o)ff) were obtained. Results. Plasma total NAC after a bolus injection showed biphasic elimination with an inflection point at 1 hr. After 1 hr, NAC was largely present in the covalent protein-bound form. During the steady state of the infusion, approximately 30%-40% of plasma NAC bound with protein covalently. The k(o)n, k(o)ff, and the elimination rate constant of protein-unbound drug (k(e)) were 0.23, 0.57, and 4.3 hr(-1). The dissociation half-life of NAC from protein estimated from k(o)ff was in agreement with the elimination half-life of plasma total NAC. This suggests that the dissociation of NAC from protein rate-limited the drug elimination in plasma (k(o)ff < k(e)). Conclusion. We demonstrated that plasma total drug clearance is kinetically limited by covalent protein binding. The compartmental model described here is useful for analyzing its kinetics in vivo.
引用
收藏
页码:615 / 620
页数:6
相关论文
共 21 条
[1]  
BOMAN G, 1983, EUR J RESPIR DIS, V64, P405
[2]  
CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
[3]   Mixed disulphide formation in myoglobin of mouse (Mus musculus) [J].
Enoki, Y ;
Ohga, Y ;
Ishidate, H ;
Sakata, S ;
Kohzuki, H ;
Hattori, M .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1996, 113 (01) :149-155
[4]   New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11 [J].
Fink, CA ;
Qiao, Y ;
Berry, CJ ;
Sakane, Y ;
Ghai, RD ;
Trapani, AJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (26) :5023-5030
[5]   Determination of reduced, protein-unbound, and total concentrations of N-acetyl-L-cysteine and L-cysteine in rat plasma by postcolumn ligand substitution high-performance liquid chromatography [J].
Harada, D ;
Naito, S ;
Kawauchi, Y ;
Ishikawa, K ;
Koshitani, O ;
Hiraoka, I ;
Otagiri, M .
ANALYTICAL BIOCHEMISTRY, 2001, 290 (02) :251-259
[6]  
HUSKISSON EC, 1974, REP RHEUM DIS, V54, P1
[7]  
JOHNSTON CI, 1979, LANCET, V2, P493
[8]  
*MICR INC, 2000, USP DI, V1
[9]   Probing the cysteine 34 residue in human serum albumin using fluorescence techniques [J].
Narazaki, R ;
Maruyama, T ;
Otagiri, M .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1338 (02) :275-281
[10]   Covalent binding between bucillamine derivatives and human serum albumin [J].
Narazaki, R ;
Hamada, M ;
Harada, K ;
Otagiri, M .
PHARMACEUTICAL RESEARCH, 1996, 13 (09) :1317-1321